Post-acute COVID-19 outcomes in children requiring hospitalisation

Cara J Bossley1, Ema Kavaliunaite2, Katharine Harman2

  • 1Department of Paediatric Respiratory Medicine, King's College Hospital NHS Foundation Trust, London, SE5 9RS, UK. cara.bossley@nhs.net.

Scientific Reports
|May 17, 2022
PubMed

Insights

Most children fully recover from SARS-CoV-2 infection. While some experience lingering symptoms like fatigue or cough, these typically resolve within three months, indicating a low incidence of post-acute COVID-19 syndrome in pediatric populations.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Post-acute sequelae of SARS-CoV-2 infection are well-documented in adults but less characterized in children.
  • Understanding long-term outcomes in pediatric COVID-19 is crucial for clinical management and public health guidance.

Purpose of the Study:

  • To assess the prevalence and nature of post-acute COVID-19 syndrome in a large cohort of children and young people.
  • To determine the recovery trajectory of pediatric patients following SARS-CoV-2 infection.

Main Methods:

  • Clinical assessments were conducted on a cohort of pediatric patients admitted with confirmed SARS-CoV-2 RNA.
  • Symptom evaluation for post-acute COVID-19 syndrome was performed at 4 weeks or more post-infection.
  • Follow-up assessments were conducted at 3 months to track symptom resolution.

Main Results:

  • The vast majority (85%) of children achieved full recovery after SARS-CoV-2 infection.
  • A small proportion experienced symptoms lasting over 4 weeks, including dry cough, fatigue, and headache.
  • Most of these prolonged symptoms resolved by the 3-month follow-up; one patient reported persistent anosmia.

Conclusions:

  • Post-acute COVID-19 syndrome appears uncommon in children and young people.
  • Most pediatric patients experience a full recovery from SARS-CoV-2 infection.
  • The long-term prognosis for pediatric COVID-19 is generally favorable, with most symptoms resolving over time.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
464
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
463
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
394
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
353
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
351
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
356